Consumers can pay a couple of hundred dollars to find out their ancestry or a couple of thousand dollars to find out their cancer risk. Not everyone agrees that this is a good idea.
This is a preview of subscription content, access via your institution
Access options
Subscribe to Journal
Get full journal access for 1 year
$99.00
only $8.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
Author information
Authors and Affiliations
Supplementary information
Related links
Related links
Related links in Nature Research
Unchecked by government, genetic tests sell hope and hype
Genetic testing for cancer susceptibility: the promise and the pitfalls
Web links
Rights and permissions
About this article
Cite this article
De Francesco, L. Genetic profiteering. Nat Biotechnol 24, 888–890 (2006). https://doi.org/10.1038/nbt0806-888
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0806-888
This article is cited by
-
Regulators weigh risks of consumer genetic tests
Nature Biotechnology (2008)